Literature DB >> 10207125

Metabolic activation of dibenzo[a,l]pyrene by human cytochrome P450 1A1 and P450 1B1 expressed in V79 Chinese hamster cells.

A Luch1, W Schober, V J Soballa, G Raab, H Greim, J Jacob, J Doehmer, A Seidel.   

Abstract

Metabolic activation of the strongly carcinogenic polycyclic aromatic hydrocarbon (PAH) dibenzo[a,l]pyrene (DB[a,l]P) and its trans-8,9-dihydrodiol (trans-8,9-diol) catalyzed by human cytochromes P450 (P450) 1A1 and 1B1 was investigated. DNA binding of DB[a,l]P in mammalian cell lines has previously been shown to be preferentially mediated by fjord region DB[a,l]P-11,12-dihydrodiol 13,14-epoxides (DB[a,l]PDE). In order to elucidate different capabilities of both P450 enzymes for metabolic activation of DB[a, l]P V79 Chinese hamster cells, stably expressing human P450s 1A1 or 1B1 have been exposed to the parent PAH or its racemic trans-8, 9-diol. For this purpose, synthesis and spectroscopic characterization of the trans-DB[a,l]P-8,9-diol and its individual enantiomers have been achieved. Both human P450-expressing cell lines were capable of transforming DB[a,l]P to its fjord region DB[a, l]PDE, but the extent of metabolism to DB[a,l]PDE catalyzed by human P450 1B1 was higher compared to human P450 1A1 at all times measured. On the other hand, cytotoxicity studies performed with the same incubation systems emerged stronger effects by DB[a,l]P and its enantiomeric trans-11,12-diols in human P450 1A1-expressing cells. Both human P450 enzymes stereospecifically catalyzed the formation of the (-)-DB[a,l]P-11,12-diol with R,R-configuration, whereas only the human P450 1A1-expressing cells form small amounts of the K-region trans-8,9-diol with high excess of the (+)-(8R, 9R)-enantiomer. Application of trans-DB[a,l]P-8,9-diol in metabolism studies revealed that this compound is converted by human P450s 1A1 and 1B1 to several diol phenols and bis-diols. However, and even at concentrations as high as 10 microM, in both cell lines the trans-DB[a,l]P-8,9-diol showed no cytotoxicity at all, suggesting that an activation of DB[a,l]P via further oxidation of the K-region trans-8,9-diol plays a minor role.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10207125     DOI: 10.1021/tx980240g

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  9 in total

Review 1.  Contributions of human enzymes in carcinogen metabolism.

Authors:  Slobodan Rendic; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-05-10       Impact factor: 3.739

Review 2.  Human Family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Arch Toxicol       Date:  2021-01-18       Impact factor: 5.153

3.  Induction of ovarian cancer and DNA adducts by Dibenzo[a,l]pyrene in the mouse.

Authors:  Kun-Ming Chen; Shang-Min Zhang; Cesar Aliaga; Yuan-Wan Sun; Timothy Cooper; Krishnegowda Gowdahalli; Junjia Zhu; Shantu Amin; Karam El-Bayoumy
Journal:  Chem Res Toxicol       Date:  2012-01-06       Impact factor: 3.739

4.  Analysis of dibenzo[def,p]chrysene-deoxyadenosine adducts in wild-type and cytochrome P450 1b1 knockout mice using stable-isotope dilution UHPLC-MS/MS.

Authors:  Tod A Harper; Jeff Morré; Fredine T Lauer; Tammie J McQuistan; Jessica M Hummel; Scott W Burchiel; David E Williams
Journal:  Mutat Res Genet Toxicol Environ Mutagen       Date:  2015-03-12       Impact factor: 2.873

5.  Chemical toxicity testing in vitro using cytochrome P450-expressing cell lines, such as human CYP1B1.

Authors:  Robert Landsiedel; Eric Fabian; Tewes Tralau; Andreas Luch
Journal:  Nat Protoc       Date:  2011-04-28       Impact factor: 13.491

6.  Cytotoxicity and mutagenicity of dibenzo[a,l]pyrene and (+/-)-dibenzo[a,l]pyrene-11,12-dihydrodiol in V79MZ cells co-expressing either hCYP1A1 or hCYP1B1 together with human glutathione-S-transferase A1.

Authors:  Mary E Kushman; Sandra L Kabler; Sarfaraz Ahmad; Johannes Doehmer; Charles S Morrow; Alan J Townsend
Journal:  Mutat Res       Date:  2007-04-19       Impact factor: 2.433

Review 7.  Inhibition of Carcinogen-Activating Cytochrome P450 Enzymes by Xenobiotic Chemicals in Relation to Antimutagenicity and Anticarcinogenicity.

Authors:  Tsutomu Shimada
Journal:  Toxicol Res       Date:  2017-04-15

Review 8.  Role of Base Excision Repair Pathway in the Processing of Complex DNA Damage Generated by Oxidative Stress and Anticancer Drugs.

Authors:  Yeldar Baiken; Damira Kanayeva; Sabira Taipakova; Regina Groisman; Alexander A Ishchenko; Dinara Begimbetova; Bakhyt Matkarimov; Murat Saparbaev
Journal:  Front Cell Dev Biol       Date:  2021-01-22

Review 9.  Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention.

Authors:  Vasilis P Androutsopoulos; Aristidis M Tsatsakis; Demetrios A Spandidos
Journal:  BMC Cancer       Date:  2009-06-16       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.